Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MAGIC-AKI: Magnesium for Cisplatin-Associated AKI
NCT05730816Phase 2Recruiting
- Sponsor
- Brigham and Women's Hospital
- Start
- Apr 2023
- Primary completion
- Apr 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of magnesium sulfate in acute kidney injury (AKI), sponsored by Brigham and Women's Hospital. Started Apr 2023; status: recruiting.
02
Drugs
magnesium sulfate
03
Conditions
acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT05730816.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05730816.